메뉴 건너뛰기




Volumn 120, Issue 6, 2009, Pages 464-466

Editorial: Transforming growth factor-β: A biomarker in marfan syndrome?

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRILLIN 1; LOSARTAN; MATRIX METALLOPROTEINASE; NEBIVOLOL; TRANSFORMING GROWTH FACTOR BETA; BIOLOGICAL MARKER;

EID: 69449108394     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.883629     Document Type: Editorial
Times cited : (9)

References (14)
  • 5
    • 58149230979 scopus 로고    scopus 로고
    • TGF-β signaling in vascular biology and dysfunction
    • Goumans MJ, Liu Z, ten Dijke P. TGF-β signaling in vascular biology and dysfunction. Cell Res. 2009;19:116-127.
    • (2009) Cell Res , vol.19 , pp. 116-127
    • Goumans, M.J.1    Liu, Z.2    Ten Dijke, P.3
  • 8
    • 34548775221 scopus 로고    scopus 로고
    • Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losar-tan) in individuals with Marfan syndrome
    • Lacro RV, Dietz HC, Wruck LM, Bradley TJ, Colan SD, Devereux RB. Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losar-tan) in individuals with Marfan syndrome. Am Heart J. 2007;154: 624-631.
    • (2007) Am Heart J , vol.154 , pp. 624-631
    • Lacro, R.V.1    Dietz, H.C.2    Wruck, L.M.3    Bradley, T.J.4    Colan, S.D.5    Devereux, R.B.6
  • 9
    • 17444380829 scopus 로고    scopus 로고
    • Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome
    • Yetman AT, Bornemeier RA, McCrindle BW. Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome. Am J Cardiol. 2005;95:1125-1127.
    • (2005) Am J Cardiol , vol.95 , pp. 1125-1127
    • Yetman, A.T.1    Bornemeier, R.A.2    McCrindle, B.W.3
  • 10
    • 34948849376 scopus 로고    scopus 로고
    • Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: A randomized controlled trial
    • Ahimastos AA, Aggarwal A, D'Orsa KM, Formosa MF, White AJ, Savarirayan R, Dart AM, Kingwell BA. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. JAMA. 2007;298:1539-1547.
    • (2007) JAMA , vol.298 , pp. 1539-1547
    • Ahimastos, A.A.1    Aggarwal, A.2    D'Orsa, K.M.3    Formosa, M.F.4    White, A.J.5    Savarirayan, R.6    Dart, A.M.7    Kingwell, B.A.8
  • 11
    • 42549132541 scopus 로고    scopus 로고
    • Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in Marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9
    • Chung AWY, Yand HHC, Radomski MW, van Breemen C. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in Marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circ Res. 2008;102:e73-e85.
    • (2008) Circ Res , vol.102
    • Chung, A.W.Y.1    Yand, H.H.C.2    Radomski, M.W.3    Van Breemen, C.4
  • 14
    • 66149129126 scopus 로고    scopus 로고
    • Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 mutations
    • Gambarin FI, Favalli V, Serio A, Regazzi M, Vigano M, Odero A, Tavazzi L, Arbustini E. Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 mutations. J Cardiovasc Med. 2009;10:354-362.
    • (2009) J Cardiovasc Med , vol.10 , pp. 354-362
    • Gambarin, F.I.1    Favalli, V.2    Serio, A.3    Regazzi, M.4    Vigano, M.5    Odero, A.6    Tavazzi, L.7    Arbustini, E.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.